+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epigenomics"

From
From
From
From
From
From
From
Omics Lab Services Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Omics Lab Services Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
Epigenomics Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Epigenomics Market - Global Forecast Report 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
From
AI Opportunities in Personalised Medicine - Product Thumbnail Image

AI Opportunities in Personalised Medicine

  • Report
  • March 2023
  • Global
From
From
DNA Sequencing - Technologies, Markets & Companies - Product Thumbnail Image

DNA Sequencing - Technologies, Markets & Companies

  • Report
  • November 2021
  • 545 Pages
  • Global
From
Personalized Medicine - Scientific & Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific & Commercial Aspects

  • Report
  • November 2021
  • 1165 Pages
  • Global
From
From
Genome Editing in Drug Discovery. Edition No. 1 - Product Thumbnail Image

Genome Editing in Drug Discovery. Edition No. 1

  • Book
  • April 2022
  • 352 Pages
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
Loading Indicator

Epigenomics is a field of genomics that studies the regulation of gene expression through chemical modifications of DNA and its associated proteins. It focuses on the heritable changes in gene expression that occur without changes in the underlying DNA sequence. These modifications, known as epigenetic marks, are involved in a variety of biological processes, including development, aging, and disease. Epigenomics research has been used to identify biomarkers for cancer diagnosis and prognosis, as well as to develop new therapeutic strategies. It has also been used to study the effects of environmental factors on gene expression, such as nutrition, stress, and exposure to toxins. The epigenomics market is expected to grow significantly in the coming years, driven by increasing investments in research and development, technological advancements, and the growing prevalence of cancer and other diseases. Some companies in the epigenomics market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, Merck KGaA, and Oxford Nanopore Technologies. Show Less Read more